Adapthealth Corp (AHCO) live share price

Adapthealth Corp share price in USD $10.03 & INR ₹849.49

$10.03

▲

0.04

(0.4%)

View live Adapthealth Corp share price in Dollar and Rupees. Guide to invest in Adapthealth Corp from India. Also see the sentimental analysis on Indian investors investing in Adapthealth Corp. Get details on the Indian mutual funds that are investing in Adapthealth Corp. Get Analyst recommendations and forecasts along with all the Adapthealth Corp's financials.

Adapthealth Corp share price movements

$9.93
$10.04
$10.03
1.0%
Downside
Day's Volatility :1.1%
Upside
0.1%
$6.43
$11.90
$10.03
35.89%
Downside
52 Weeks Volatility :45.97%
Upside
15.71%

Adapthealth Corp Returns

Period	Adapthealth Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	-7.81%	-6.2%	0.0%
6 Months	4.81%	2.6%	0.0%
1 Year	9.02%	11.8%	0.0%
3 Years	-49.85%	13.3%	-19.8%

Adapthealth Corp Key Statistics

in dollars & INR

Market Capitalization	$1.3B
Revenue TTM	$3.3B
EBITDA	$669.4M
Earnings Per Share (EPS)	$-1.67
Profit Margin	-6.57%
Quarterly Earnings Growth YOY	0.44%
Return On Equity TTM	-12.88%

How to invest in Adapthealth Corp from India?

It is very easy for Indian residents to invest directly in Adapthealth Corp from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Adapthealth Corp stock in both rupees (INR) and dollars (USD). Search for Adapthealth Corp or AHCO on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Adapthealth Corp or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Adapthealth Corp shares which would translate to 0.084 fractional shares of Adapthealth Corp as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Adapthealth Corp

80%

Period: Sep 2, 2024 to Dec 1, 2024. Change in 30 Days versus previous period

Search volume for Adapthealth Corp on INDmoney from India has grown in the last 30 days as on Dec 2, 2024. 80% more investors are searching Adapthealth Corp in the last 30 days versus the previous period.

Global Institutional Holdings in Adapthealth Corp

OEP CAPITAL ADVISORS, L.P.
10.27%
BlackRock Inc
10.09%
Vanguard Group Inc
9.33%
Deerfield Management Co
7.22%
FMR Inc
5.46%
Reinhart Mahoney Capital Management Inc
4.61%

Analyst Recommendation on Adapthealth Corp

Buy

68%Buy

25%Hold

6%Sell

Based on 16 Wall street analysts offering stock ratings for Adapthealth Corp(by analysts ranked 0 to 5 stars)

Based on 16 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Adapthealth Corp

What analysts predicted

Upside of 13.55%

Current:

$10.03

Target:

$11.39

Insights on Adapthealth Corp

Decreasing Revenue
Revenue is down for the last 2 quarters, 805.97M → 805.85M (in $), with an average decrease of 0.0% per quarter
Increasing Net Profit
Netprofit is up for the last 5 quarters, -454.07M → 22.85M (in $), with an average increase of 3007.6% per quarter
Vs BSX
In the last 1 year, Boston Scientific Corp. has given 61.5% return, outperforming this stock by 47.9%
Vs BSX
In the last 3 years, Boston Scientific Corp. has given 128.9% return, outperforming this stock by 176.0%

Adapthealth Corp Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$345.3M	↑ 79.31%
Net Income	$2.1M	↓ 302432.46%
Net Profit Margin	0.6%	↑ 0.6%

	FY19	Y/Y Change
Revenue	$529.6M	↑ 53.4%
Net Income	$12.2M	↑ 486.6%
Net Profit Margin	2.31%	↑ 1.71%

	FY20	Y/Y Change
Revenue	$1.1B	↑ 99.45%
Net Income	$-58.7M	↓ 579.84%
Net Profit Margin	-5.56%	↓ 7.87%

	FY21	Y/Y Change
Revenue	$2.5B	↑ 132.35%
Net Income	$156.2M	↓ 365.97%
Net Profit Margin	6.36%	↑ 11.92%

	FY22	Y/Y Change
Revenue	$3.0B	↑ 21.02%
Net Income	$69.3M	↓ 55.62%
Net Profit Margin	2.33%	↓ 4.03%

	FY23	Y/Y Change
Revenue	$3.2B	↑ 7.73%
Net Income	$-678.9M	↓ 1079.42%
Net Profit Margin	-21.21%	↓ 23.54%

	Q2 FY23	Q/Q Change
Revenue	$793.3M	↑ 6.53%
Net Income	$14.0M	↓ 11.01%
Net Profit Margin	1.76%	↓ 0.35%

	Q3 FY23	Q/Q Change
Revenue	$804.0M	↑ 1.35%
Net Income	$-454.1M	↓ 3348.74%
Net Profit Margin	-56.47%	↓ 58.23%

	Q4 FY23	Q/Q Change
Revenue	$858.2M	↑ 6.74%
Net Income	$-254.5M	↓ 43.95%
Net Profit Margin	-29.65%	↑ 26.82%

	Q1 FY24	Q/Q Change
Revenue	$792.5M	↓ 7.66%
Net Income	$-2.1M	↓ 99.16%
Net Profit Margin	-0.27%	↑ 29.38%

	Q2 FY24	Q/Q Change
Revenue	$806.0M	↑ 1.7%
Net Income	$19.4M	↓ 1010.73%
Net Profit Margin	2.41%	↑ 2.68%

	Q3 FY24	Q/Q Change
Revenue	$805.9M	↓ 0.01%
Net Income	$22.9M	↑ 17.62%
Net Profit Margin	2.84%	↑ 0.43%

	FY18	Y/Y Change
Total Assets	$254.1M	↑ 81713.0%
Total Liabilities	$8.6M	↑ 2894.8%

	FY19	Y/Y Change
Total Assets	$227.8M	↓ 10.34%
Total Liabilities	$212.7M	↑ 2380.62%

	FY20	Y/Y Change
Total Assets	$1.8B	↑ 701.57%
Total Liabilities	$1.4B	↑ 573.03%

	FY21	Y/Y Change
Total Assets	$5.3B	↑ 187.5%
Total Liabilities	$3.2B	↑ 122.41%

	FY22	Y/Y Change
Total Assets	$5.2B	↓ 0.59%
Total Liabilities	$3.1B	↓ 3.83%

	FY23	Y/Y Change
Total Assets	$4.5B	↓ 13.62%
Total Liabilities	$3.0B	↓ 0.65%

	Q2 FY23	Q/Q Change
Total Assets	$5.2B	↓ 1.52%
Total Liabilities	$3.0B	↓ 3.21%

	Q3 FY23	Q/Q Change
Total Assets	$4.7B	↓ 9.18%
Total Liabilities	$3.0B	↓ 1.01%

	Q4 FY23	Q/Q Change
Total Assets	$4.6B	↓ 2.23%
Total Liabilities	$3.2B	↑ 5.62%

	Q1 FY24	Q/Q Change
Total Assets	$4.5B	↓ 2.51%
Total Liabilities	$3.0B	↓ 3.82%

	Q2 FY24	Q/Q Change
Total Assets	$4.5B	↑ 0.16%
Total Liabilities	$3.0B	↓ 0.47%

	Q3 FY24	Q/Q Change
Total Assets	$4.5B	↓ 0.91%
Total Liabilities	$2.9B	↓ 2.4%

	FY18	Y/Y Change
Operating Cash Flow	$68.4M	↑ 48.98%
Investing Cash Flow	$-96.3M	↑ 538.6%
Financing Cash Flow	$251.3M	↑ 209657.17%

	FY19	Y/Y Change
Operating Cash Flow	$60.4M	↓ 11.7%
Investing Cash Flow	$-84.9M	↓ 11.85%
Financing Cash Flow	$-13.9M	↓ 105.53%

	FY20	Y/Y Change
Operating Cash Flow	$195.6M	↑ 223.8%
Investing Cash Flow	$-815.7M	↑ 861.12%
Financing Cash Flow	$643.2M	↓ 4729.33%

	FY21	Y/Y Change
Operating Cash Flow	$275.7M	↑ 40.92%
Investing Cash Flow	$-1.8B	↑ 123.7%
Financing Cash Flow	$1.6B	↑ 148.58%

	FY22	Y/Y Change
Operating Cash Flow	$373.9M	↑ 35.62%
Investing Cash Flow	$-411.2M	↓ 77.47%
Financing Cash Flow	$-66.1M	↓ 104.13%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$86.3M	↓ 38.45%
Investing Cash Flow	$-100.2M	↑ 11.87%
Financing Cash Flow	$-42.4M	↓ 1053.19%

Adapthealth Corp Technicals Summary

Sell

Neutral

Buy

Adapthealth Corp is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Adapthealth Corp Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Adapthealth Corp	-1.18%	4.81%	9.02%	-49.85%	0.2%
Stryker Corporation	6.88%	15.55%	34.78%	58.85%	91.88%
Boston Scientific Corp.	7.01%	20.08%	65.53%	129.75%	110.79%
Edwards Lifesciences Corp.	7.34%	-18.79%	3.14%	-34.23%	-13.05%
Abbott Laboratories	0.95%	15.46%	12.91%	-8.83%	39.43%
Medtronic Plc	-3.1%	5.38%	8.5%	-19.02%	-22.69%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Adapthealth Corp	64.08	NA	NA	0.92	-0.13	0.04	NA	11.52
Stryker Corporation	41.65	41.65	2.71	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	75.0	75.0	1.65	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	27.55	27.55	6.61	2.53	0.19	0.11	NA	16.18
Abbott Laboratories	36.16	36.16	2.31	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	26.38	26.38	1.56	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Adapthealth Corp	Buy	$1.3B	0.2%	64.08	-6.57%
Stryker Corporation	Buy	$148.0B	91.88%	41.65	16.34%
Boston Scientific Corp.	Buy	$133.8B	110.79%	75.0	11.26%
Edwards Lifesciences Corp.	Buy	$42.1B	-13.05%	27.55	65.86%
Abbott Laboratories	Buy	$206.3B	39.43%	36.16	13.99%
Medtronic Plc	Buy	$110.6B	-22.69%	26.38	12.06%

About Adapthealth Corp

at adapthealth, we believe everyone deserves a comfortable and independent life with access to products and services tailored to empower patients to live their best lives -- out of the hospital and in their homes. we are a full-service home medical equipment and respiratory company with operations in 46 states offering a breadth of clinically-focused products and services to help patients with daily activities of life including: sleep and respiratory therapy, mobility products, wound care, non-invasive ventilation and nutrition.

Organization	Adapthealth Corp
Employees	10700
CEO	Mr. Jason A. Clemens C.F.A.
Industry	Finance

Important FAQs about investing in Adapthealth Corp from India :

What is Adapthealth Corp share price today?

Adapthealth Corp (AHCO) share price today is $10.03.

Can Indians buy Adapthealth Corp shares?

Yes, Indians can invest in the Adapthealth Corp (AHCO) from India.

With INDmoney, you can buy Adapthealth Corp at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Adapthealth Corp at zero transaction cost.

How can I buy Adapthealth Corp shares from India?

It is very easy to buy Adapthealth Corp from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Adapthealth Corp be purchased?

Yes, you can buy fractional shares of Adapthealth Corp with INDmoney app.

What are the documents required to start investing in Adapthealth Corp stocks?

To start investing in Adapthealth Corp, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Adapthealth Corp

Today’s highest price of Adapthealth Corp (AHCO) is $10.04.

Today’s lowest price of Adapthealth Corp (AHCO) is $9.93.

What is today's market capitalisation of Adapthealth Corp

Today's market capitalisation of Adapthealth Corp AHCO is 1.3B

What is the 52 Week High and Low Range of Adapthealth Corp

52 Week High
$11.90
52 Week Low
$6.43

How much percentage Adapthealth Corp is down from its 52 Week High?

Adapthealth Corp (AHCO) share price is $10.03. It is down by 99% from its 52 Week High price of $11.90.

How much percentage Adapthealth Corp is up from its 52 Week low?

Adapthealth Corp (AHCO) share price is $10.03. It is up by 1% from its 52 Week Low price of $6.43.

What are the historical returns of Adapthealth Corp?

1 Month Returns
-1.18%
3 Months Returns
4.81%
1 Year Returns
9.02%
5 Years Returns
0.2%

Who is the Chief Executive Officer (CEO) of Adapthealth Corp

Mr. Jason A. Clemens C.F.A. is the current Chief Executive Officer (CEO) of Adapthealth Corp.

Discover More

Explore all